Lonza Cell & Gene Technologies

Lonza is a pioneer and world leader in the CDMO industry, dedicated to serving the healthcare industry. Founded in Switzerland in 1897 as the first and original CDMO, the company brings together a team of 20,000 colleagues across five continents to deliver integrated offerings that meet the complex needs of the global customer community.

Core Mission & Values

Lonza's vision is to be the pioneer and world leader in the CDMO industry, setting the pace with cutting-edge science, smart technology, and lean manufacturing. The company's purpose is to turn customers' breakthrough innovations into viable therapies and manufacture the medicines of tomorrow. Core values include integrity, collaboration, passion, accountability, and excellence.

Service Offerings

Lonza Bioscience provides life science researchers and manufacturers with tools and services spanning:

• Discovery tools: Primary cells, cell culture, and transfection technologies for research
• Protein production & bioprocessing: Cell culture media for large-scale manufacturing of biologics and therapies
• Endotoxin and pyrogen testing: Complete testing solutions for raw materials, in-process samples, and manufactured products
• Cell and gene therapy solutions: Research and GMP media, reagents, electroporation technology, and primary cells from first experiment to final dose
• Quality control tests and software for biomanufacturing